Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 16 , ISSUE 1 ( January-March, 2022 ) > List of Articles


Guidelines for Invasive Prenatal Procedures

Giovanni Monni, Ambra Iuculano, Cristina Peddes

Keywords : Diagnosis, Guidelines, Invasive prenatal procedures, Pathologies of chromosomal and/or genetic origin

Citation Information : Monni G, Iuculano A, Peddes C. Guidelines for Invasive Prenatal Procedures. Donald School J Ultrasound Obstet Gynecol 2022; 16 (1):83-90.

DOI: 10.5005/jp-journals-10009-1913

License: CC BY-NC 4.0

Published Online: 22-04-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Invasive prenatal diagnosis is a series of procedures necessary to obtain fetal or embryo-fetal tissues useful for diagnosing pathologies of chromosomal and/or genetic origin. It can also be used for detecting infectious agents, metabolism errors, and/or for studying the composition of fetal fluids such as blood and urine. Most common prenatal techniques are chorionic villus sampling, amniocentesis, and cordocentesis. They are options to choose from according to the gestational age and the type of fetal pathology to investigate.

  1. Milunsky A and Milunsky JM. Genetic Disorders and the Fetus. Diagnosis, Prevention and Treatment. 6th Ed.: Wiley-Blackwell Publisher 2010.
  2. Douglas Wilson R. The role of invasive testing in prenatal diagnosis of hereditable diseases; Invasive fetal testing and treatment, edited by Christopher R. Harman 1995, 3–19. Blackwell Scientific Publications
  3. Milunsky A and Milunsky JM. Genetic counseling: Preconception, Prenatal and Perinatal. In: Genetic Disorders and the Fetus; 1–62; Diagnosis, Prevention and Treatment. 6th Ed.: Wiley–Blackwell Publisher 2010.
  4. Ghi T, Sotiriadis A, Calda P, et al. ISUOG practice guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol 2017;49(3):414–415. DOI: 10.1002/uog.15945
  5. Cicero S, Bindra R, Rembouskos G, et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003;23(4):306–310. DOI: 10.1002/pd.588
  6. Monni G, Zoppi MA. Improved first-trimester aneuploidy risk assessment: an evolving challenge of training in invasive prenatal diagnosis. Ultrasound Obstet Gynecol 2013;41(5):486–488. DOI: 10.1002/uog.12461
  7. American College of Obstetricians and Gynecologists Committee on Genetics Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120(6):1532–1534 DOI: 10.1097/01.AOG.0000423819.85283.f4
  8. Nicolaides KH, Chervenak FA, McCullough LB, et al. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193(2):322–326. DOI: 10.1016/j.ajog.2005.02.134
  9. Cao A, Rosatelli MC, Monni G, et al. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002;29(2): 305–328, vi–vii. DOI: 10.1016/s0889-8545(01)00006-7
  10. American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 88, december 2007. invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110(6):1459–1467 DOI: 10.1097/01.AOG.0000291570.63450.44
  11. Monni G, Zoppi MA, Axiana C, et al. Changes in the approach for invasive prenatal diagnosis in 35,127 cases at a single center from 1977 to 2004. Fetal Diagn Ther 2006;21(4);348–354. DOI: 10.1159/000092464
  12. Spencer JW, Cox DN. A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy. Obstet Gynecol 1988;72(5):714–718. PMID: 3173922.
  13. Chueh JT, Goldberg JD, Wohlferd MM, et al. Comparison of transcervical and transabdominal chorionic villus sampling loss rates in nine thousand cases from a single center. Am J Obstet Gynecol 1995;173(4):1277–1282. DOI: 10.1016/0002-9378(95)91370-x
  14. Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003;(3):CD003252. DOI: 10.1002/14651858.cd003252
  15. Nicolaides KH, Rodeck CH, Soothill PW, Warren RC, Gosden CM. Why confine chorionic villus (placental) biopsy to the first trimester? Lancet 1986;1:543–544. DOI:
  16. Monni G, Pagani G, Stagnati V, et al. How to perform transabdominal chorionic villus sampling: a practical guideline. J Matern Fetal Neonatal Med 2016;29(9):1499–1505. DOI: 10.3109/14767058.2015.1051959
  17. Brambati B, Oldrini A, Lanzani A. Transabdominal chorionic villus sampling: a freehand ultrasound guided technique. Am J Obstet Gynecol 1987;157(1):134–137. DOI: 10.1016/s0002-9378(87)80363-0
  18. Firth HV, Boyd PA, Chamberlain P, et al. Severe limb abnormalities after chorion villus sampling at 56–66 days’ gestation. Lancet 1991;337(8744):762–763. DOI: 10.1016/0140-6736(91)91374-4
  19. Monni G, Ibba RM, Lai R, et al. Limb-reduction defects and chorion villus sampling. Lancet 1991;337(8749):1091-1092. DOI: 10.1016/0140-6736(91)91735-D
  20. Ibba RM, Monni G, Lai R et al. Total fetal malformations following chorion villus sampling. Prenat Diagn 1992; 12(suppl):S98.
  21. Smidt-Jensen S, Hahnemann N. Transabdominal fine needle biopsy from chorionic villi in the first trimester. Prenat Diagn 1984;4(3):163–169 DOI: 10.1002/pd.1970040302
  22. Monni G, Ibba RM, Lai R et al. Early transabdominal chorionic villus sampling in couples at high genetic risk. Am J Obstet Ginecol 1993;168(1 Pt 1):170–173. DOI: 10.1016/s0002-9378(12)90908-4
  23. Monni G, Zoppi MA, Ibba RM. Prenatal genetic diagnosis through chorionic villus sampling. In: Milunsky A and Milunsky JM. Genetic Disorders and the Fetus: Diagnosis, Prevention, Treatment. 6th Ed.: Wiley–Blackwell Publisher 2010, p. 160–193
  24. Brambati B, Oldrini A, Aladerun SA. Transcervical specimen of chorionic villi in the 1st trimester of pregnancy. Pathologica 1983;75(Suppl):179–183. PMID: 6680423.
  25. Dumez Y, Goossens M, Poenaru L, et al. Biopsy of chorionic villi by forceps under ultrasonic control: technic and results. J Genet Hum 1984;32(5):335–344. PMID: 6527129.
  26. Monni G, Ibba RM, Olla G, et al. Chorionic villus sampling by rigid forceps: experience with 300 cases at risk for thalassemia major. Am J Obstet Gynecol 1987;156(4):912–914. DOI: 10.1016/0002-9378(87)90352-8
  27. Monni G, Olla G, Cao A. Patient's choice between transcervical and transabdominal chorionic villus sampling. Lancet 1988;331(8593):1057.
  28. Jackson L, Zachary J, Fowler S et al. A randomised comparison of transcervical and transabdominal chorionic villus sampling. The U.S. national institute of child health and human development chorionic-villus sampling and amniocentesis study group. New Engl J Med 1992;327(9):594–598. DOI: 10.1056/NEJM199208273270903
  29. Pergament E, Schulman JD, Copeland K et al. The risk and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn 1992;12(5):377–384. DOI: 10.1002/pd.1970120507
  30. Brambati B, Tului L, Guercilena S, et al. Outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy. Ultrasound Obstet Gynecol 2001;17(3):209–216. DOI: 10.1046/j.1469-0705.2001.00379.x
  31. G Monni, M A Zoppi, G Cau, R Lai, M Baldi et al. Importance of nuchal translucency measurement in multifetal pregnancy reduction. Ultrasound Obstet Gynecol 1999;13:377–378. PMID: 10380312.
  32. Monni G, Iuculano A. Re: ISUOG practice guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol 2017;49(3):414–415. DOI: 10.1002/uog.17375
  33. Gagnon A, Davies G, Wilson RD, et al. Prenatal invasive procedures in women with hepatitis B, hepatitis C, and/or human immunodeficiency virus infections. J Obstet Gynaecol Can 2014;36(7):648–655. DOI: 10.1016/S1701-2163(15)30546-6
  34. Somigliana F, Bucceri AM, Tibaldi C et al. Early invasive diagnostic technique in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005;193 (2):437–442. DOI: 10.1016/j.ajog.2004.12.087
  35. Rhoads GG, Jackson LG, Schlesselman SE et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989;320(10):609–617. DOI: 10.1056/NEJM198903093201001
  36. Ledbetter DH, Zachary JM, Simpson JL et al. Cytogenetic results from the U.S. collaborative study on CVS. Prenat Diagn 1992;12(5):317–345. DOI: 10.1002/pd.1970120503
  37. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367(23):2175–2184 DOI: 10.1056/NEJMoa1203382
  38. Grati FR, Molina Gomes D, Ferreira JC et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn 2015;35(8):801–809. DOI: 10.1002/pd.4613
  39. Malvestiti F, Agrati C, Grimi B et al.. Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis. Prenat Diagn 2015; 35(11):1117–1127. DOI: 10.1002/pd.4656
  40. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1–7. DOI: 10.1159/000271995
  41. Norton ME, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;373(26):2582. DOI: 10.1056/NEJMc1509344
  42. Monni G, Pagani G, Illescas T et al. Training for transabdominal villous sampling is feasible and safe. Am J Obstet Gynecol 2015;213(2):248–250. DOI: 10.1016/j.ajog.2015.04.019
  43. Wulff CB, Gerds TA, Rode L et al. Risk of fetal loss associated with invasive testing following combined first-trimester screening for down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol 2016;47(1):38–44. DOI: 10.1002/uog.15820
  44. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998;351(9098):242–247.
  45. Royal College of Obstetricians and Gynecologists. Amniocentesis and chorionic villus sampling. Guidelines No. 8. London RCOG Press; 2005.
  46. Sepulveda W, Sebire NJ, Hughes K, et al. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 1996;7(6):421–423. DOI: 10.1046/j.1469-0705.1996.07060421.x
  47. Nicolini U, Monni G. Intestinal obstruction in babies exposed in utero to methylene blue. Lancet 1990;336(8725):1258–1259. DOI: 10.1016/0140-6736(90)92879-M
  48. Tongsong T, Wanapirak C, Sirivatanapa P, et al. Amniocentesis-related fetal loss: a cohort study. Obstet Gynecol 1998;92(1):64–67. DOI: 10.1016/s0029-7844(98)00125-2
  49. Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015;45(1):16–26. DOI: 10.1002/uog.14636
  50. Cederholm M, Haglund B, Axelsson O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 2003;110 (4), 392–399. DOI: 10.1046/j.1471-0528.2003.02091.x
  51. Davies G, Wilson RD, Désilets V, et al. Society of obstetricians and gynaecologists of Canada. amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can 2003;25(2):145–148, 149–152. DOI: 10.1016/s1701-2163(16)30211-0
  52. Welch RA, Salem-Elgharib S, Wiktor AE, et al. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol 2006;194(1):189–191. DOI: 10.1016/j.ajog.2005.05.033
  53. Nizard J, Duyme M, Ville Y. Teaching ultrasound-guided invasive procedures in fetal medicine: learning curves with and without an electronic guidance system. Ultrasound Obstet Gynecol 2002;19(3):274–277. DOI: 10.1046/j.1469-0705.2002.00647.x
  54. Ludomirsky A. Intrauterine fetal blood sampling a multicentric registry: evaluation of 7462 procedures between 1987 and 1991. Am J Obstet Gynecol 1993;168:31
  55. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 1985;153(6):655–660. DOI: 10.1016/s0002-9378(85)80254-4
  56. Berry SM, Stone J, Norton ME, et al. Fetal blood sampling. Am J Obstet Gynecol 2013;(3):170–180. DOI: 10.1016/j.ajog.2013.07.014
  57. Nicolaidis P, Nicolini U, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein for rapid karyotyping in the second and third trimesters. Br J Radiol 1991;64(762):505–509. DOI: 10.1259/0007-1285-64-762-505
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.